Novavax's COVID vaccine brought in sales of $38.21 million for ... US epidemic of sexually transmitted infections shows signs ...

In August, the Food and Drug Administration authorized updated vaccines against COVID-19. Here's what to know about the three ...

H.C. Wainwright analyst Vernon Bernardino reiterated a Buy rating on Novavax (NVAX – Research Report) today and set a price target of ...

Adults 65 and older and people with weakened immune systems should get two doses of the newly updated COVID-19 vaccine, the ...

The U.S. Food and Drug Administration has lifted its clinical hold on a late-stage trial of Novavax's COVID-influenza and its standalone flu vaccines, the company said on Monday.

There is an exception for those choosing to receive a Novavax vaccine, according to the CDC. If you are getting a shot for the first time, you need two Novavax vaccines to be considered “up to date.” ...

The vaccine helps to prevent bacterial infections that can cause serious illness in older adults, such as pneumonia.

Novavax (NVAX) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.

This article summarizes key developments in the health sector including a lawsuit blocking UnitedHealth's purchase of ...

With flu season underway and new, developing COVID-19 strains, health professionals continue to stress the importance of receiving an updated vaccine. On Oct. 23, the Centers for Disease Control ...